GlassScriptPhysician profile
Marsilia S Cloud
NPI 1043257462
$1,970.45
in general payments reported to CMS, 2019-2025
35 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $209 · 2021: $14.71 · 2022: $281 · 2023: $335 · 2024: $239 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.43 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $180.22 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $155.21 | 2019-2022 | |
| Abbvie INC. | $128.44 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $116.81 | 2022-2023 | |
| Amgen INC. | $111.76 | 2019-2025 | Prolia, Evenity |
| Coopersurgical, INC. | $110.49 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $97.43 | 2019-2025 | Slynd |
| Merck Sharp & Dohme LLC | $95.22 | 2019-2022 | |
| Novo Nordisk INC | $92.29 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $89.28 | 2019 | |
| Hologic Sales and Service, LLC | $84.34 | 2019-2024 | Aptima |
| Medtronic, INC. | $63.73 | 2023-2024 | Truclear |
| Duchesnay USA Incorporated | $57.28 | 2019 | |
| Mylan Pharmaceuticals INC. | $57.05 | 2022 | |
| Exact Sciences Corporation | $43.97 | 2023 | Cologuard Collection Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $43.80 | 2019-2025 | |
| Daiichi Sankyo INC. | $43.25 | 2019 | |
| Millicent US INC | $41.63 | 2019-2020 | |
| Boston Scientific Corporation | $39.98 | 2023 | Solyx Sis System |
| Allergan, INC. | $37.73 | 2019 | |
| Ge Healthcare | $28.95 | 2019 | |
| Vertical Pharmaceuticals, LLC | $26.12 | 2019 | |
| Gilead Sciences, INC. | $25.95 | 2022 | |
| Biogen, INC. | $25.62 | 2025 | Zurzuvae |
| Becton, Dickinson and Company | $19.41 | 2023 | Bd Onclarity |
| Meditrina | $18.43 | 2023 | |
| Sumitomo Pharma America, INC. | $17.77 | 2023 | Myfembree |
| Pfizer INC. | $15.99 | 2020 | |
| Mission Pharmacal Company | $15.88 | 2019 | |
| Organon LLC | $15.87 | 2024 | |
| Si-Bone, INC. | $15.50 | 2019 | |
| Bausch Health US, LLC | $15.39 | 2019 | |
| Mckesson Patient Care Solutions INC. | $14.25 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.41 | 2019 | |
| Minerva Surgical, INC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marsilia Cloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.